Cellectis S.A.

Cellectis S.A.verified

ALCLS.PA

Price:

$2.065

Market Cap:

$159.57M

Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALLO-501A to treat relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma; ALLO-316 for the treatment of Renal Cell Carcinoma; UCART123 for the treatment of acute myeloid leukemia; and UCART22 to treat B-cell acute lymphoblastic leuke...[Read more]

Industry

Biotechnology

IPO Date

2007-02-07

Stock Exchange

EURONEXT

Ticker

ALCLS.PA

The PE Ratio as of September 2024 (TTM) for Cellectis S.A. (ALCLS.PA) is -1.86

According to Cellectis S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -1.86. This represents a change of -270.00% compared to the average of 1.09 of the last 4 quarters.

Cellectis S.A. (ALCLS.PA) Historical PE Ratio (quarterly & annually)

How has ALCLS.PA PE Ratio performed in the past?

The mean historical PE Ratio of Cellectis S.A. over the last ten years is 1.58K. The current -1.86 PE Ratio has changed -111.81% with respect to the historical average. Over the past ten years (40 quarters), ALCLS.PA's PE Ratio was at its highest in in the March 2015 quarter at 41.06. The PE Ratio was at its lowest in in the June 2018 quarter at -41.80.

Quarterly (TTM)
Annual

Average

1.58K

Median

-8.58

Minimum

-46.33

Maximum

15.86K

Cellectis S.A. (ALCLS.PA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cellectis S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 111.77%

Maximum Annual PE Ratio = 15.86K

Minimum Annual Increase = -2042735.59%

Minimum Annual PE Ratio = -46.33

Quarterly (TTM)
Annual
YearPE RatioChange
2023-1.7275.14%
2022-0.98-77.67%
2021-4.39-74.75%
2020-17.41111.77%
2019-8.22-8.08%
2018-8.94-15.39%
2017-10.5712.28%
2016-9.41-79.68%
2015-46.33-100.29%
201415.86K-2042735.59%

Cellectis S.A. (ALCLS.PA) Average PE Ratio

How has ALCLS.PA PE Ratio performed in the past?

The current PE Ratio of Cellectis S.A. (ALCLS.PA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-2.36

5-year avg

-6.54

10-year avg

1.58K

Cellectis S.A. (ALCLS.PA) PE Ratio vs. Peers

How is ALCLS.PA’s PE Ratio compared to its peers?

Cellectis S.A.’s PE Ratio is greater than Innate Pharma S.A. (-14.59), greater than Genfit S.A. (-6.79), greater than Nanobiotix S.A. (-4.77), greater than Adocia SA (-2.39), less than DBV Technologies S.A. (-0.87),

CompanyPE RatioMarket cap
-14.59$165.95M
-6.79$196.68M
-4.77$209.83M
-2.39$85.73M
-0.87$69.26M

Build a custom stock screener for Cellectis S.A. (ALCLS.PA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cellectis S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cellectis S.A. (ALCLS.PA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cellectis S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Cellectis S.A.'s PE Ratio?

How is the PE Ratio calculated for Cellectis S.A. (ALCLS.PA)?

What is the highest PE Ratio for Cellectis S.A. (ALCLS.PA)?

What is the 3-year average PE Ratio for Cellectis S.A. (ALCLS.PA)?

What is the 5-year average PE Ratio for Cellectis S.A. (ALCLS.PA)?

How does the current PE Ratio for Cellectis S.A. (ALCLS.PA) compare to its historical average?